Showing results (1531-1540 of 1,967) with videos related to

Sort By:
Pageof 197
Journal of Pediatric Surgery|March 16, 2023
Pediatric Surgery from the Roads Less Traveled: Challenges, Communication, and Collaboration from a Community Nonteaching HospitalEllen Reynolds, Matthew Muffly, Katie Apple, et al.
Blood Advances|June 23, 2026
SAVE, Safe Accelerated Venetoclax Escalation: A phase Ib study of obinutuzumab plus venetoclax with daily ramp-up in CLLJennifer L Crombie, Inhye E Ahn, Yue Ren, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2015
Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reportingE Wardelmann, R L Haas, J V M G Bovée, et al.
Scientific Reports|May 16, 2019
Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampusSimone Granno, Jonathon Nixon-Abell, Daniel C Berwick, et al.
The Journal of Cell Biology|November 2, 2005
Cytoplasmic dynein nomenclatureK Kevin Pfister, Elizabeth M C Fisher, Ian R Gibbons, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 28, 2019
Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma CentreC Drabbe, C Benson, E Younger, et al.
Npj Antimicrobials and Resistance|May 29, 2026
Addressing the dual-use of antifungals and fungal antimicrobial resistance (fAMR) through a One Health approachS Weeks, A Brown, K Doughty, et al.
Clinical Immunology (Orlando, Fla.)|November 5, 2018
A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activityE M D Smith, A Eleuteri, B Goilav, et al.
Plos One|September 23, 2016
Fully-Automated μMRI Morphometric Phenotyping of the Tc1 Mouse Model of Down SyndromeNick M Powell, Marc Modat, M Jorge Cardoso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2011
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemiaPhilip C Amrein, Eyal C Attar, Tak Takvorian, et al.
Pageof 197